Epizyme, Inc.;GlaxoSmithKline Intellectual Property Development Limited
发明人:
申请号：
EP15830530.0
公开号：
EP3177288A4
申请日:
2015.08.04
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
Described herein are methods of treating cancer using one or more PRMT5 inhibitors, for example using one or more compounds of Formulae (1-5) or (A-F), pharmaceutically acceptable salts thereof, and/or pharmaceutical compositions thereof. Described herein are methods of treating cancer using one or more PRMT5 inhibitors, for example using one or more compounds of Formulae (1-5) or (A-F), pharmaceutically acceptable salts thereof, and/or pharmaceutical compositions thereof.
